ClinicalTrials.Veeva

Menu

Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia

H

HaEmek Medical Center, Israel

Status

Completed

Conditions

MRI
Iron Overload
Sickle Cell Thalassemia
Sickle Cell Anemia

Treatments

Other: Cardiac and Liver T2* MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT00512226
0037-07-EMC

Details and patient eligibility

About

Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't develope significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpouse of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and cardiac T2*MRI in order to determine the cardiac and liver iron.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All the patients with Sickle cell anemia and Sickle cell Thalasemia that are currently in follow up at the Pediatric Hematology Unit

Exclusion criteria

  • Age below 18 years.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems